Results 61 to 70 of about 15,220 (305)

Preparation and characterization of vaginal suppository of semisynthetic derivatives of ergot alkaloids cabergoline

open access: yesSaudi Pharmaceutical Journal, 2023
Background: There is evidence that vaginal cabergoline can help to prevent ovarian hyperstimulation syndrome. Therefore, the vaginal suppository may be a good choice because it can be administered directly into the vagina and has no adverse effects on ...
Pouria Rahmanian-Devin   +3 more
doaj   +1 more source

Increased expression of 5-hydroxytryptamine(2A/B) receptors in idiopathic pulmonary fibrosis: a rationale for therapeutic intervention [PDF]

open access: yes, 2010
Background Idiopathic pulmonary fibrosis (IPF) has a poor prognosis and limited responsiveness to available treatments. It is characterised by epithelial cell injury, fibroblast activation and proliferation and extracellular matrix deposition ...
Amarie, Oana Veronica   +8 more
core   +1 more source

The Effect of Preoperative Cabergoline on Prolactinoma Fibrosis: A Case Series

open access: yesJournal of Neurological Surgery Reports
Introduction  Prolactinomas are a common intracranial neoplasm and constitute most pituitary tumors. Although patients can present with variable hormone dysregulation and symptom severity, the use of dopamine agonists remains a first-line treatment ...
Isabella L. Pecorari   +5 more
semanticscholar   +1 more source

Structures of cabergoline anhydrate form II and novel cabergoline solvates

open access: yesStructural Chemistry, 2006
Crystal forms of N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-6-allyl-ergoline-8β-carboxamide (cabergoline) originating from various solvents have been examined by X-ray diffraction at 298 or 150 K. Crystal structures of cabergoline anhydrate, (form II, P212121) and solvates (all P212121) with tert-butyl methyl ether (form VIII), cyclohexane (form XV)
Bohumil Kratochvíl   +6 more
openaire   +4 more sources

Long-Term Results of Cabergoline Add-on Long-Acting Somatostatin Analogue Therapy in Acromegaly Patients

open access: yesGazi Medical Journal
Objective: To investigate the efficacy of the dopamine agonist cabergoline in uncontrolled acromegaly despite long-acting somatostatin analog (SSA). Methods: Thirty-five patients with acromegaly who were followed up in the department of endocrinology ...
Mehmet Muhittin Yalçın   +13 more
doaj   +1 more source

Impulse Control Disorders in Southern Iraqi Patients Medicated With Cabergoline for Prolactinoma

open access: yesCureus
Background: Among the patient population in Basrah, Iraq, prolactinoma is the most commonly found pituitary tumor. Impulse control disorders (ICDs) were reportedly associated with these patients being treated with cabergoline.
Mohammad M Mohammad   +2 more
semanticscholar   +1 more source

De Novo Psychiatric Disorders in a Woman With Giant Prolactinoma Treated With Cabergoline

open access: yesClinical Medicine Insights: Case Reports, 2023
Dopamine agonists are the first-line treatment of prolactinomas. The risk of developing de novo psychiatric symptoms during dopamine agonist therapy is low.
Chayma Belhadj Slimane   +4 more
doaj   +1 more source

Successful Management of a Giant Pituitary Lactosomatotroph Adenoma Only with Cabergoline

open access: yesCase Reports in Endocrinology, 2013
Although advances in endocrinologic and neuroradiologic research allow easier recognition of pituitary adenomas, giant pituitary tumours are relatively rare.
Emre Bozkirli   +5 more
doaj   +1 more source

Novel Medicine for Endometriosis and Its Therapeutic Effect in a Mouse Model

open access: yesBiomedicines, 2020
Current therapeutic medicines for endometriosis cannot be administered during assisted reproductive technology (ART) because they have bad effects during pregnancy.
Young Sang Kim   +5 more
doaj   +1 more source

Cabergoline Treatment in Invasive Giant Prolactinoma [PDF]

open access: yesClinical Medicine Insights: Case Reports, 2014
Patients with invasive giant prolactinoma suffer from a constellation of symptoms including headache, blurred vision, lethargy, and sexual dysfunction. Cabergoline, a potent dopamine agonist, is a known medication prescribed for the treatment of invasive giant prolactinoma.
Mussa H. Almalki, Sadeem Alsubaie
openaire   +5 more sources

Home - About - Disclaimer - Privacy